| 1 | [SID103050643] | Active | IC50 | 4.52 | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage - Set 2 [AID602211, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | IC50 | 4.52 [uM] | | BioAssay | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage - Set 2 | | AID | 602211 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID103050643] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID103050643] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID103050643] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID103050643] | Active | Potency | 7.3078 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID103050643] | Active | Potency | 7.3078 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID103050643] | Active | Potency | 7.3078 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID103050643] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 9 | [SID103050643] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 10 | [SID103050643] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 11 | [SID103050643] | Active | | | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay [AID588493, Type: screening] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay | | AID | 588493 | | BioAssay type | screening | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 12 | [SID103050643] | Active | | | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay [AID651999, Type: screening] | COPS5 gene product [Homo sapiens] [gi:38027923] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay | | AID | 651999 | | BioAssay type | screening | | Target | COPS5 gene product [Homo sapiens] [gi:38027923] | | PubMed | | | Data Table |  |
|
| 13 | [SID103050643] | Active | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) [AID651572, Type: screening] | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) | | AID | 651572 | | BioAssay type | screening | | Target | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] | | PubMed | | | Data Table |  |
|
| 14 | [SID103050643] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) [AID651608, Type: screening] | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) | | AID | 651608 | | BioAssay type | screening | | Target | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] | | PubMed | | | Data Table |  |
|
| 15 | [SID103050643] | Active | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID103050643] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts [AID651611, Type: screening] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts | | AID | 651611 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID103050643] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 18 | [SID103050643] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 19 | [SID103050643] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 20 | [SID103050643] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 21 | [SID103050643] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 22 | [SID103050643] | Active | | | Luminescence-based cell-based high throughput confirmation assay for biased ligands (agonists) of the melanocortin 4 receptor (MC4R) [AID602192, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for biased ligands (agonists) of the melanocortin 4 receptor (MC4R) | | AID | 602192 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 23 | [SID103050643] | Active | | | Luminescence-based cell-based high throughput confirmation assay for biased ligands (agonists) of the melanocortin 4 receptor (MC4R) [AID602192, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for biased ligands (agonists) of the melanocortin 4 receptor (MC4R) | | AID | 602192 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 24 | [SID103050643] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 25 | [SID103050643] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 26 | [SID103050643] | Active | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | PAX8 [Homo sapiens] [gi:998701] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Active | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | PAX8 [Homo sapiens] [gi:998701] | | PubMed | | | Data Table |  |
|
| 27 | [SID103050643] | Inactive | IC50 | 10.1 | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage using 2-dexoy-glucose - Set 2 [AID602210, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | IC50 | 10.1 [uM] | | BioAssay | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage using 2-dexoy-glucose - Set 2 | | AID | 602210 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID103050643] | Inactive | IC50 | 22.2 | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage in HL-1 cells using 2-dexoy-glucose [AID602217, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | IC50 | 22.2 [uM] | | BioAssay | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage in HL-1 cells using 2-dexoy-glucose | | AID | 602217 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID103050643] | Inactive | IC50 | 79 | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage [AID588779, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | IC50 | 79 [uM] | | BioAssay | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage | | AID | 588779 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID103050643] | Inactive | IC50 | 79 | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage using 2-dexoy-glucose [AID588780, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | IC50 | 79 [uM] | | BioAssay | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage using 2-dexoy-glucose | | AID | 588780 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID103050643] | Inactive | IC50 | 79 | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage in HL-1 cells using Peroxide [AID602215, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | IC50 | 79 [uM] | | BioAssay | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage in HL-1 cells using Peroxide | | AID | 602215 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID103050643] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 33 | [SID103050643] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 34 | [SID103050643] | Inactive | | | Single concentration confirmation of uHTS inhibitor hits from RPN11 in a Fluorescence Polarization assay [AID602318, Type: screening] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | Single concentration confirmation of uHTS inhibitor hits from RPN11 in a Fluorescence Polarization assay | | AID | 602318 | | BioAssay type | screening | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 35 | [SID103050643] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 36 | [SID103050643] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 37 | [SID103050643] | Inactive | | | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay [AID602244, Type: screening] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay | | AID | 602244 | | BioAssay type | screening | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 38 | [SID103050643] | Inactive | | | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay [AID602244, Type: screening] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay | | AID | 602244 | | BioAssay type | screening | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 39 | [SID103050643] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 40 | [SID103050643] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 41 | [SID103050643] | Inactive | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | Il2 gene product [Mus musculus] [gi:7110653] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | Il2 gene product [Mus musculus] [gi:7110653] | | PubMed | | | Data Table |  |
|
| 42 | [SID103050643] | Inactive | | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity [AID602393, Type: screening] | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602393 | | BioAssay type | screening | | Target | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] | | PubMed | | | Data Table |  |
|
| 43 | [SID103050643] | Inactive | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] | | PubMed | | | Data Table |  |
|
| 44 | [SID103050643] | Inactive | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] | | PubMed | | | Data Table |  |
|
| 45 | [SID103050643] | Inactive | Potency | | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | TAR DNA-binding protein 43 [gi:20140568] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | TAR DNA-binding protein 43 [gi:20140568] | | PubMed | | | Data Table |  |
|
| 46 | [SID103050643] | Inactive | | | uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay [AID588489, Type: screening] | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay | | AID | 588489 | | BioAssay type | screening | | Target | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] | | PubMed | | | Data Table |  |
|
| 47 | [SID103050643] | Inactive | | | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity [AID651658, Type: screening] | FGF22 gene product [Homo sapiens] [gi:10190672] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651658 | | BioAssay type | screening | | Target | FGF22 gene product [Homo sapiens] [gi:10190672] | | PubMed | | | Data Table |  |
|
| 48 | [SID103050643] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624377, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624377 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|
| 49 | [SID103050643] | Inactive | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID602281, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 602281 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 50 | [SID103050643] | Inactive | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | ERAP1 protein [Homo sapiens] [gi:21315078] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103050643 | | CID | 49778412 | | Outcome | Inactive | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | ERAP1 protein [Homo sapiens] [gi:21315078] | | PubMed | | | Data Table |  |
|